Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 31.57 USD 4.09% Market Closed
Market Cap: 1.9B USD

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 51.94 USD with a low forecast of 40.4 USD and a high forecast of 65.1 USD.

Lowest
Price Target
40.4 USD
28% Upside
Average
Price Target
51.94 USD
65% Upside
Highest
Price Target
65.1 USD
106% Upside
Twist Bioscience Corp Competitors:
Price Targets
PHARM
Pharming Group NV
498% Upside
PRME
Prime Medicine Inc
344% Upside
2256
Abbisko Cayman Ltd
25% Upside
SNDX
Syndax Pharmaceuticals Inc
214% Upside
SLNO
Soleno Therapeutics Inc
45% Upside
FHTX
Foghorn Therapeutics Inc.
142% Upside
IVACC
Intervacc AB
549% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Twist Bioscience Corp

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

62%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
51.94 USD

According to Wall Street analysts, the average 1-year price target for TWST is 51.94 USD with a low forecast of 40.4 USD and a high forecast of 65.1 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

Back to Top